Advanced Renal Cell Carcinoma Unknown Status Phase 1 Trials for Evofosfamide (DB06091)

Also known as: Advanced Renal cell carcinoma

IndicationStatusPhase
DBCOND0032596 (Advanced Renal Cell Carcinoma)Unknown Status1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01381822Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine TumorsTreatment